Target Validation Information
Target ID T55959
Target Name Sodium-dependent dopamine transporter
Target Type
Successful
Drug Potency against Target ISOTETRANDRINE Drug Info IC50 = 4200 nM
SECOCULARIDINE Drug Info IC50 = 13400 nM
1-Benzo[b]thiophen-2-yl-cyclohexylamine Drug Info IC50 = 123 nM [1]
1-Benzo[b]thiophen-2-yl-cyclopentylamine Drug Info IC50 = 630 nM [1]
N,Ndimethyl milnacipran Drug Info IC50 = 4500 nM [2]
Bip-tyr(3bzl)-thr-pro-lys-thr Drug Info IC50 = 10000 nM [3]
AMINOBENZTROPINE Drug Info IC50 = 373 nM [4]
1-(1,4-diphenylbutan-2-yl)piperazine Drug Info IC50 = 400 nM [5]
DIMETHYLGRISABINE Drug Info IC50 = 1100 nM
Methyl 2-(naphthalen-2-yl)benzoate Drug Info Ki = 4060 nM [6]
Cis-3-phenoxy-2,3-dihydro-1H-inden-1-amine Drug Info IC50 = 2000 nM [7]
(RS/SR)-2-[1-(4-chlorophenyl)pentyl]piperidine Drug Info IC50 = 170 nM [8]
(RS/SR)-2-[1-(4-chlorophenyl)hexyl]piperidine Drug Info IC50 = 650 nM [8]
(RS/SR)-2-[1-(4-chlorophenyl)ethyl]piperidine Drug Info IC50 = 1500 nM [8]
ANONAINE Drug Info IC50 = 800 nM
4-(2-(3-fluorophenoxy)-4-methylphenyl)piperidine Drug Info Ki = 1450 nM [9]
4-(2-(benzyloxy)-3-fluorophenyl)piperidine Drug Info Ki = 7370 nM [9]
1-(2-(4-fluorophenoxy)phenyl)piperazine Drug Info Ki = 4420 nM [9]
2-(2,3-Dihydro-1H-indol-5-yl)-1-methyl-ethylamine Drug Info IC50 = 3800 nM [10]
Benzyl-(2-phenyl-quinazolin-4-yl)-amine Drug Info Ki = 7900 nM [11]
4-(2-phenoxyphenyl)piperidine Drug Info Ki = 284 nM [9]
1-(1-Benzo[b]thiophen-2-yl-cyclopentyl)-azepane Drug Info IC50 = 21 nM [1]
NORBOLDINE Drug Info IC50 = 16500 nM
RTI-336 Drug Info IC50 = 4.09 nM [12]
1-(naphthalen-2-yl)-3-aza-bicyclo[3.1.0]hexane Drug Info IC50 = 190 nM [13]
1-(thiophen-2-yl)-3-aza-bicyclo[3.1.0]hexane Drug Info IC50 = 7500 nM [13]
1-(4-aminophenyl)-2-pyrrolidin-1-yl-pentan-1-one Drug Info IC50 = 7 nM [14]
PYROVALERONE Drug Info IC50 = 32 nM [14]
(+/-)-threo-N-(2-Chlorobenzyl)methylphenidate Drug Info IC50 = 243 nM [15]
PSEUDOCOCAINE Drug Info Ki = 13800 nM [16]
GB-12819 Drug Info Ki = 595 nM [17]
10R-hydroxylobel-7-ene Drug Info Ki = 290 nM [18]
ANTIOQUINE Drug Info IC50 = 3400 nM
4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one Drug Info Ki < 1000 nM [19]
2-Amino-1-(4-methylthiophenyl)propane Drug Info IC50 = 3073 nM [20]
2-((2-iodophenoxy)(phenyl)methyl)morpholine Drug Info Ki = 410 nM [21]
Methylphenidate Drug Info Ki = 17 nM [22]
4-(2-fluoro-6-(2-fluorophenoxy)phenyl)piperidine Drug Info Ki = 278 nM [23]
1-(3,4-dichlorophenyl)-3-aza-bicyclo[3.1.0]hexane Drug Info IC50 = 380 nM [13]
2-(Aminomethyl)-5-(1'-naphthyl)tetrahydrofuran Drug Info IC50 = 463 nM [24]
2-(Aminomethyl)-5-(2'-naphthyl)tetrahydrofuran Drug Info IC50 = 28 nM [24]
LITOXETINE Drug Info IC50 = 6700 nM [25]
Bip-tyr-thr-pro-lys-thr(obzl)-gly Drug Info IC50 = 1800 nM [3]
Bip-tyr-thr-pro-thr(obzl)-gly Drug Info IC50 = 300 nM [3]
(2R,3R)-iodoreboxetine Drug Info Ki = 716 nM [26]
WIN-35066-2 Drug Info IC50 = 23 nM [27]
D-257C Drug Info Ki = 66.5 nM [28]
(+/-)-threo-3',5'-Dichloromethylphenidate Drug Info IC50 = 65.6 nM [15]
1S,2R-milnacipran Drug Info IC50 = 3200 nM [29]
O-methyldauricine Drug Info IC50 = 5800 nM
ANOLOBINE Drug Info IC50 = 8100 nM
1-(3-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one Drug Info IC50 = 52 nM [30]
1-(2-(2-chlorophenyl)-1-phenylethyl)piperazine Drug Info IC50 = 1300 nM [31]
4-(2-fluoro-6-(3-fluorophenoxy)phenyl)piperidine Drug Info Ki = 139 nM [9]
1-(2-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one Drug Info IC50 = 63 nM [30]
4-(3-fluoro-2-phenoxyphenyl)piperidine Drug Info Ki = 239 nM [9]
2-Aminomethyl-5-(p-t-butylphenyl)tetrahydrofuran Drug Info IC50 = 4301 nM [24]
2-(tert-butylamino)-1-p-tolylpropan-1-one Drug Info IC50 = 1950 nM [32]
2-(Aminomethyl)-5-phenethyltetrahydrofuran Drug Info IC50 = 513 nM [24]
4-(2-(benzyloxy)-6-fluorophenyl)piperidine Drug Info Ki = 1030 nM [9]
1-(3-chlorophenyl)-2-(piperidin-1-yl)propan-1-one Drug Info IC50 = 852 nM [32]
4-(2-(2-fluorobenzyloxy)phenyl)piperidine Drug Info Ki = 1810 nM [9]
2-(N-Pyrrolidinyl)-3'-fluoropropiophenone Drug Info IC50 = 156 nM [32]
(R)-3-(naphthalen-2-ylmethoxy)pyrrolidine Drug Info IC50 = 3800 nM [33]
4-(2-(4-fluorobenzyloxy)phenyl)piperidine Drug Info Ki = 9120 nM [9]
3-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol Drug Info IC50 = 1400 nM [31]
2-(tert-Butylamino)-3',4'-dichloropentanophenone Drug Info Ki = 43.7 nM [34]
2-(tert-Butylamino)-3',5'-difluoropropiophenone Drug Info IC50 = 5600 nM [34]
8-Methyl-3-p-tolyl-8-aza-bicyclo[3.2.1]octane Drug Info IC50 = 10.2 nM [35]
2-(N-Cyclopentylamino)-3'-fluoropropiophenone Drug Info IC50 = 693 nM [32]
D-211B Drug Info Ki = 8.63 nM [28]
D-211A Drug Info Ki = 41.8 nM [28]
R-NORDULOXETINE Drug Info Ki = 3549 nM [36]
2-(N-Pyrrolidinyl)-3'-methylpropiophenone Drug Info IC50 = 414 nM [32]
2-Aminomethyl-5-(p-bromophenyl)tetrahydrofuran Drug Info IC50 = 167 nM [24]
2-(N-Isopropylamino)-3'-chloropropiophenone Drug Info Ki = 3980 nM [34]
1-(3,4-Dichloro-phenyl)-3-diethylamino-indan-5-ol Drug Info Ki = 40 nM [37]
1-(4-nitrophenyl)-2-pyrrolidin-1-yl-pentan-1-one Drug Info IC50 = 1110 nM [30]
1-(4-bromophenyl)-2-(tert-butylamino)propan-1-one Drug Info IC50 = 689 nM [32]
2pyrrolidin-1-yl-1-phenylpentan-1-one Drug Info IC50 = 52.3 nM [30]
4-(2-fluoro-6-phenoxyphenyl)piperidine Drug Info Ki = 45 nM [9]
2-(tert-Butylamino)-3',4'-dichlorobutyrophenone Drug Info IC50 = 175 nM [34]
4-(2-(3-fluorophenoxy)phenyl)piperidine Drug Info Ki = 166 nM [9]
2-Aminomethyl-5-(phenyl)tetrahydrofuran Drug Info IC50 = 147 nM [24]
2-(N-Cyclopentylamino)-3'-bromopropiophenone Drug Info IC50 = 845 nM [32]
(R)-Norfluoxetine Drug Info IC50 = 7133 nM [38]
8S-hydroxylobelane Drug Info Ki = 1260 nM [18]
1-(1-phenyl-2-(2-propoxyphenyl)ethyl)piperazine Drug Info Ki = 1950 nM [39]
10S-hydroxylobelane Drug Info Ki = 1390 nM [18]
8R-hydroxylobelane Drug Info Ki = 1880 nM [18]
(2S,3S)-iodoreboxetine Drug Info Ki = 1457 nM [26]
1-(2-(2-methoxyphenyl)-1-phenylethyl)piperazine Drug Info IC50 = 11000 nM [31]
3-Phenyl-2-nortropene Drug Info Ki = 1222 nM [40]
2-(N-Cyclopropylamino)-3-chloropropiophenone Drug Info IC50 = 265 nM [34]
4-(2-(4-fluorophenoxy)-4-methylphenyl)piperidine Drug Info Ki = 1680 nM [9]
2-(N-tert-Butylamino)-3'-chloropentanophenone Drug Info IC50 = 33 nM [34]
3-(3,4-dichlorophenyl)-2-nortropene Drug Info Ki = 16 nM [40]
4-(2-(phenoxymethyl)phenyl)piperidine Drug Info Ki = 396 nM [9]
Threo-1-aza-5-phenyl[4.4.0]decane hydrochloride Drug Info IC50 = 244 nM [41]
7-(piperidin-4-ylmethoxy)-2-naphthonitrile Drug Info IC50 = 8800 nM [33]
4-(2-fluoro-6-(4-fluorophenoxy)phenyl)piperidine Drug Info Ki = 6 nM [9]
2-(N-tert-Butylamino)-4'-chloropropiophenone Drug Info Ki = 2195 nM [34]
1-Biphenyl-4-yl-3-aza-bicyclo[3.1.0]hexane Drug Info IC50 = 2300 nM [13]
METHYLENEDIOXYMETHAMPHETAMINE Drug Info IC50 = 1442 nM [20]
(R)-N-isobutyl-N-(pyrrolidin-3-yl)-2-naphthamide Drug Info IC50 = 9500 nM [25]
8R-hydroxylobel-9-ene Drug Info Ki = 44 nM [42]
(S)-3-(naphthalen-2-ylmethoxy)pyrrolidine Drug Info IC50 = 15000 nM [33]
2-Aminomethyl-5-(p-methoxyphenyl)tetrahydrofuran Drug Info IC50 = 668 nM [24]
6-(3-aza-bicyclo[3.1.0]hexan-1-yl)quinoline Drug Info IC50 = 3900 nM [13]
2-(2'-Aminoethyl)-5-benzyltetrahydrofuran Drug Info IC50 = 565 nM [24]
1-naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one Drug Info IC50 = 40 nM [30]
Threo-ritalinol methyl ether hydrochloride Drug Info IC50 = 281 nM [41]
2-phenoxy-3-(piperidin-4-yl)pyridine Drug Info Ki = 4310 nM [23]
2-(2-methoxyphenoxy)-3-(piperidin-4-yl)pyridine Drug Info Ki = 6410 nM [23]
2-(N,N-Diethylamino)-3'-chloropropiophenone Drug Info IC50 = 1744 nM [34]
1-(4-iodophenyl)-2-pyrrolidin-1-yl-pentan-1-one Drug Info IC50 = 32 nM [30]
(2R,3S)-2-[(2-Iodophenoxy)phenylmethyl]morpholine Drug Info Ki = 525.9 nM [43]
[3-(3,4-Dichloro-phenyl)-indan-1-yl]-methyl-amine Drug Info Ki = 2 nM [37]
1-(3,4-Dichloro-phenyl)-3-methylamino-indan-5-ol Drug Info Ki = 11 nM [37]
DIFLUOROBENZTROPINE Drug Info Ki = 4.11 nM [44]
1-phenyl-3-aza-bicyclo[3.1.0]hexane Drug Info IC50 = 2700 nM [13]
D-254C Drug Info Ki = 10.6 nM [28]
WIN-35065-2 Drug Info IC50 = 23 nM [45]
1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX) Drug Info Ki = 2620 nM [39]
(+/-)-threo-N-Benzyl-3'-chloromethylphenidate Drug Info IC50 = 41.2 nM [15]
8S-hydroxylobel-9-ene Drug Info Ki = 960 nM [18]
(+/-)-threo-N-(2-Methylfuran)methylphenidate Drug Info IC50 = 536 nM [15]
10S-hydroxylobel-7-ene Drug Info Ki = 110 nM [18]
Bip-tyr-thr-pro-lys-thr Drug Info IC50 = 19000 nM [3]
(+/-)-threo-N-(4-Chlorobenzyl)methylphenidate Drug Info IC50 = 31.2 nM [15]
1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX) Drug Info Ki = 3160 nM [39]
(+/-)-threo-N-(3-Methylthiopene)methylphenidate Drug Info IC50 = 143 nM [15]
(+/-)-threo-Ritalinol methyl ether Drug Info IC50 = 97.1 nM [15]
METHYLENEDIOXYAMPHETAMINE Drug Info IC50 = 890 nM [46]
COCAINE.HCL Drug Info IC50 = 404 nM [41]
Bip-tyr-thr-pro-ala-thr(obzl)-gly Drug Info IC50 = 1700 nM [3]
Bip-tyr-thr-ala-pro-phe Drug Info IC50 = 900 nM [3]
3-(4-Fluorophenyl)-2-nortropene Drug Info Ki = 1056 nM [40]
Threo-ritalinol hydrochloride Drug Info IC50 = 1520 nM [41]
Bip-tyr-ala-pro-lys-thr(obzl)-gly Drug Info IC50 = 11000 nM [3]
(+/-)-threo-N-(3-Phenylpropyl)methylphenidate Drug Info IC50 = 267 nM [15]
(+/-)-threo-4'-Ethylmethylphenidate Drug Info IC50 = 737 nM [15]
2-(tert-Butylamino)-3'-fluoropropiophenone Drug Info Ki = 4510 nM [34]
(+/-)-threo-N-(4-Methylpyridine)methylphenidate Drug Info IC50 = 128 nM [15]
3-(4-Chlorophenyl)-2-nortropene Drug Info Ki = 231 nM [40]
(+/-)-threo-N-(2-Methylthiopene)methylphenidate Drug Info IC50 = 224 nM [15]
(+/-)-threo-N-Methyl-30-methylmethylphenidate Drug Info IC50 = 108 nM [15]
2-(2-chlorophenoxy)-3-(piperidin-4-yl)pyridine Drug Info Ki = 5150 nM [23]
2-phenylpiperidine hydrochloride Drug Info IC50 = 8800 nM [41]
4-(2-(3-chlorophenoxy)phenyl)piperidine Drug Info Ki = 310 nM [9]
(+/-)-threo-N-(2-Phenylethyl)ritalinol Drug Info IC50 = 1430 nM [15]
(+/-)-threo-Benzylphenidate Drug Info IC50 = 1020 nM [15]
(+/-)-threo-N-Allylmethylphenidate Drug Info IC50 = 597 nM [15]
(+/-)-threo-N-Ethylritalinol Drug Info IC50 = 2340 nM [15]
1-(1-Benzo[b]thiophen-2-yl-cyclohexyl)-azepane Drug Info IC50 = 18 nM [1]
1-(2-phenoxyphenyl)piperazine Drug Info Ki = 4730 nM [9]
2-(tert-butylamino)-1-m-tolylpropan-1-one Drug Info IC50 = 1470 nM [32]
1-Benzo[b]thiophen-2-yl-cycloheptylamine Drug Info IC50 = 416 nM [1]
4-(2-((3-fluorophenoxy)methyl)phenyl)piperidine Drug Info Ki = 461 nM [9]
(+/-)-threo-3',4'-Dichlororitalinol Drug Info IC50 = 4.2 nM [15]
2-(N-Pyrrolidinyl)-3'-bromopropiophenone Drug Info IC50 = 750 nM [32]
(+/-)-threo-3',4'-Dichlororitalinol methyl ether Drug Info IC50 = 1.7 nM [15]
4-(2-(4-fluorophenoxy)phenyl)piperidine Drug Info Ki = 13 nM [9]
4-(2-(benzyloxy)phenyl)piperidine Drug Info Ki = 1000 nM [9]
1-(3-chlorophenyl)-2-(dimethylamino)propan-1-one Drug Info IC50 = 1750 nM [32]
2-(N-tert-Butylamino)-3'-chlorohexanophenone Drug Info IC50 = 69 nM [34]
Threo-3,4-dichlororitalinol hydrochloride Drug Info IC50 = 22.5 nM [41]
Trans-3-(o-tolyloxy)-2,3-dihydro-1H-inden-1-amine Drug Info IC50 = 600 nM [7]
2-(N-Cyclopentylamino)-3'-chloropropiophenone Drug Info IC50 = 980 nM [34]
(+/-)-threo-N-Benzyl-3',4'-dichlororitalinol Drug Info IC50 = 2.74 nM [15]
(+/-)-threo-3',4'-Dichloromethylphenidate amide Drug Info IC50 = 16.4 nM [15]
1-(benzofuran-2-yl)-3-aza-bicyclo[3.1.0]hexane Drug Info IC50 = 330 nM [13]
N-Benzylmethylphenidate Drug Info IC50 = 52.9 nM [15]
(+/-)-threo-N-(3-Chlorobenzyl)methylphenidate Drug Info IC50 = 106 nM [15]
(+/-)-threo-N-Propargylmethylphenidate Drug Info IC50 = 821 nM [15]
2-(tert-butylamino)-1-(3-chlorophenyl)butan-1-one Drug Info IC50 = 209 nM [32]
(+/-)-threo-N-(6-Phenylhexyl)methylphenidate Drug Info IC50 = 656 nM [15]
(+/-)-threo-N-(3-Methylfuran)methylphenidate Drug Info IC50 = 459 nM [15]
1-phenyl-1-(piperidin-2-yl)propan-2-one Drug Info IC50 = 190 nM [8]
3-p-Tolyl-8-aza-bicyclo[3.2.1]octane Drug Info IC50 = 33.6 nM [35]
(+/-)-threo-N-(3-Phenylpropyl)ritalinol Drug Info IC50 = 194 nM [15]
(+/-)-threo-N-(5-Phenylpentyl)methylphenidate Drug Info IC50 = 1570 nM [15]
2-(N-tert-Butylamino)-3'-chlorooctanophenone Drug Info IC50 = 135 nM [34]
(+/-)-threo-N-(2-Methylpyridine)methylphenidate Drug Info IC50 = 369 nM [15]
(+/-)-threo-Methylphenidate amide Drug Info IC50 = 1730 nM [15]
(+/-)-threo-N-(3-Methylpyridine)methylphenidate Drug Info IC50 = 173 nM [15]
(RS/SR)-2-[1-(3,4-dichlorophenyl)butyl]piperidine Drug Info Ki = 43 nM [8]
1-(3-bromophenyl)-2-(tert-butylamino)propan-1-one Drug Info IC50 = 511 nM [32]
(+/-)-threo-N-(4-Nitrobenzyl)methylphenidate Drug Info IC50 = 113 nM [15]
2-(N-tert-Butylamino)-3',4'-dichloropropiophenone Drug Info IC50 = 271 nM [34]
(RS/SR)-2-[1-(4-chlorophenyl)propyl]piperidine Drug Info IC50 = 2800 nM [8]
(2R,3S)-2-[(4-Iodophenoxy)phenylmethyl]morpholine Drug Info Ki = 2100 nM [43]
Erythro-3,4-dichloromethylphenidate hydrochloride Drug Info IC50 = 317 nM [41]
3-(4-Trifluoromethylphenyl)-2-nortropene Drug Info Ki = 1494 nM [40]
(cis)-1,6-diphenyl-3-aza-bicyclo[3.1.0]hexane Drug Info IC50 = 8700 nM [13]
2-Aminomethyl-5-(p-chlorophenyl)tetrahydrofuran Drug Info IC50 = 313 nM [24]
(+/-)-threo-Ritalinol Drug Info IC50 = 448 nM [15]
(+/-)-threo-3-Fluororitalinol Drug Info IC50 = 281 nM [15]
1-(1-Benzo[b]thiophen-2-yl-cycloheptyl)-azepane Drug Info IC50 = 67 nM [1]
2-(N-tert-Butylamino)-3'-chloroheptanophenone Drug Info Ki = 709 nM [34]
(+/-)-threo-3',5'-Dimethylmethylphenidate Drug Info IC50 = 4690 nM [15]
PF-526014 Drug Info Ki = 2650 nM [39]
1-(3-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one Drug Info IC50 = 62.9 nM [30]
(+/-)-threo-N-(2-Phenylethyl)methylphenidate Drug Info IC50 = 678 nM [15]
(+/-)-threo-N-(4-Phenylbutyl)ritalinol Drug Info IC50 = 623 nM [15]
Threo-N-ethylritalinol hydrochloride Drug Info IC50 = 10400 nM [41]
(+/-)-threo-N-(4-Methoxybenzyl)methylphenidate Drug Info IC50 = 79.1 nM [15]
4-(2-(2-fluoro-5-methylphenoxy)phenyl)piperidine Drug Info Ki = 1080 nM [9]
1-(2-(phenoxymethyl)phenyl)piperazine Drug Info Ki = 701 nM [9]
2-(N-tert-Butylamino)propiophenone Drug Info Ki = 5730 nM [34]
1-(4-bromophenyl)-2-pyrrolidin-1-yl-pentan-1-one Drug Info IC50 = 39.5 nM [30]
2-(N-Pyrrolidinyl)-3'-nitropropiophenone Drug Info IC50 = 10000 nM [32]
(+/-)-threo-N-Benzylmethylphenidate amide Drug Info IC50 = 384 nM [15]
4-(2-pyrrolidin-1-yl-pentanoyl)benzonitrile Drug Info IC50 = 1000 nM [30]
(RS/SR)-2-[1-(4-chlorophenyl)butyl]piperidine Drug Info IC50 = 450 nM [8]
6-(piperidin-4-ylmethoxy)-2-naphthonitrile Drug Info IC50 = 6000 nM [33]
(+/-)-3-((naphthalen-2-yloxy)methyl)pyrrolidine Drug Info IC50 = 1000 nM [33]
(R)-2-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol Drug Info Ki = 2070 nM [39]
Benzhydryl-(2-phenyl-quinazolin-4-yl)-amine Drug Info Ki = 530 nM [11]
Biphenyl-2-ylmethyl-(S)-pyrrolidin-3-yl-amine Drug Info Ki = 2470 nM [47]
2-(N-Cyclopentylamino)-3'-methylpropiophenone Drug Info IC50 = 842 nM [32]
1-(4-fluorophenyl)-2-pyrrolidin-1-yl-pentan-1-one Drug Info IC50 = 185 nM [30]
(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol Drug Info IC50 = 1065 nM [48]
2-(N-Pyrrolidinyl)-3'-methoxypropiophenone Drug Info IC50 = 452 nM [32]
2-(N-Cyclopentylamino)-3'-methoxypropiophenone Drug Info IC50 = 2270 nM [32]
1-benzylpiperidine hydrochloride Drug Info IC50 = 1060 nM [41]
D-257A Drug Info Ki = 204 nM [28]
WIN-35065 Drug Info IC50 = 23 nM [49]
(R)-DULOXETINE Drug Info IC50 = 660 nM [50]
10R-hydroxylobelane Drug Info Ki = 570 nM [18]
Para-chloroamphetamine Drug Info IC50 = 424 nM [20]
ISOPILINE Drug Info IC50 = 2500 nM
2-((3-iodophenyl)(o-tolyloxy)methyl)morpholine Drug Info Ki = 740 nM [21]
RTI-219 Drug Info IC50 = 5.7 nM [49]
HOMOAROMOLINE Drug Info IC50 = 10900 nM
3alpha-(bis-chloro-phenylmethoxy)tropane Drug Info IC50 = 23.4 nM [44]
(1-Phenyl-ethyl)-(2-phenyl-quinazolin-4-yl)-amine Drug Info Ki = 1800 nM [11]
3-alpha-Phenylmethoxy-3-beta-phenyl-nortropane Drug Info Ki = 117 nM [40]
D-166A Drug Info Ki = 82.9 nM [28]
PF-18298 Drug Info Ki = 544 nM [39]
PF-3409409 Drug Info Ki = 2290 nM [51]
(+/-)-threo-N-(4-Phenylbutyl)methylphenidate Drug Info IC50 = 205 nM [15]
1-(1-(benzo[b]thiophen-2-yl)cyclohexyl)piperidine Drug Info IC50 = 12 nM [52]
Vanoxerine Drug Info IC50 = 0.8 nM [53]
(2R,3S)-2-[(3-Iodophenoxy)phenylmethyl]morpholine Drug Info Ki = 1900 nM [43]
(S)-Norfluoxetine Drug Info IC50 = 6488 nM [38]
1-(2,3-Dihydro-1H-indol-5-ylmethyl)-propylamine Drug Info IC50 = 10000 nM [10]
COCLAURINE Drug Info IC50 = 14100 nM
(2S,3S)-2-(m-Tolyl)-3,5,5-trimethylmorpholin-2-ol Drug Info IC50 = 2600 nM [48]
NORSTEPHALAGINE Drug Info IC50 = 1400 nM
R-226161 Drug Info Ki = 583 nM [54]
OBABERINE Drug Info IC50 = 3900 nM
WIN_35428 Drug Info IC50 = 21 nM [45]
[N-[2-[(3'-N'-PROPYL-3''ALPHA-(BIS(4-FLUORORPHENYL)METHOXY)TROPANE-2''BETA-CARBOXYLIC ACID METHYL ESTER)(2-MERCAPTOETHYL)AMINO]ACETYL]-2-AMINOETHANETHIOLATO]RHENIUM(V) OXIDE (DIASTEREOMERIC MIX) Drug Info IC50 = 616 nM [55]
NISOXETINE Drug Info IC50 = 2400 nM [7]
References
REF 1J Med Chem. 1993 Apr 30;36(9):1188-93.Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites.
REF 2Bioorg Med Chem Lett. 2008 Feb 15;18(4):1346-9. Epub 2008 Jan 9.Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.
REF 3J Med Chem. 2006 Jul 13;49(14):4048-51.Development of peptidic dopamine transporter inhibitors via aromatic modification-mediated conformational restriction.
REF 4J Med Chem. 1997 Mar 14;40(6):851-7.3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
REF 5Bioorg Med Chem Lett. 2006 Aug 15;16(16):4349-53. Epub 2006 Jun 5.Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.
REF 6Bioorg Med Chem. 2007 Jun 15;15(12):4159-74. Epub 2007 Mar 30.Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.
REF 7Bioorg Med Chem Lett. 2008 Jul 15;18(14):4224-7. Epub 2008 May 20.Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).
REF 8J Med Chem. 2007 Jan 25;50(2):219-32.Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.
REF 9Bioorg Med Chem Lett. 2009 Dec 1;19(23):6604-7. Epub 2009 Oct 12.Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.
REF 10J Med Chem. 1986 Aug;29(8):1406-12.Selective monoamine oxidase inhibitors. 3. Cyclic compounds related to 4-aminophenethylamine. Preparation and neuron-selective action of some 5-(2-aminoethyl)-2,3-dihydroindoles.
REF 11Identification of a novel partial inhibitor of dopamine transporter among 4-substituted 2-phenylquinazolines. Bioorg Med Chem Lett. 2002 Aug 19;12(16):2225-8.
REF 12Effects of dopamine transporter selective 3-phenyltropane analogs on locomotor activity, drug discrimination, and cocaine self-administration after oral administration. Eur J Pharmacol. 2006 Dec 28;553(1-3):149-56. Epub 2006 Sep 23.
REF 13Bioorg Med Chem Lett. 2008 Jul 1;18(13):3682-6. Epub 2008 May 23.Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors.
REF 14Bioorg Med Chem. 2009 Jun 1;17(11):3770-4. Epub 2009 May 3.A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone.
REF 15Bioorg Med Chem. 2010 Oct 15;18(20):7221-38. Epub 2010 Aug 19.Quantitative structure-activity relationship studies of threo-methylphenidate analogs.
REF 16Bioorg Med Chem Lett. 1999 Jul 5;9(13):1831-6.Synthesis of 8-Oxa analogues of norcocaine endowed with interesting cocaine-like activity.
REF 17Bioorg Med Chem Lett. 2002 Sep 2;12(17):2387-90.Synthesis and dopamine transporter binding affinities of 3alpha-benzyl-8-(diarylmethoxyethyl)-8-azabicyclo[3.2.1]octanes.
REF 18Bioorg Med Chem Lett. 2006 Oct 1;16(19):5018-21. Epub 2006 Aug 14.Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters.
REF 19J Med Chem. 2010 Sep 9;53(17):6386-97.Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.
REF 20Eur J Med Chem. 2009 Dec;44(12):4862-88. Epub 2009 Aug 6.Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.
REF 21Bioorg Med Chem Lett. 2007 Jan 15;17(2):533-7. Epub 2006 Oct 12.Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER.
REF 22Therapeutic potential of monoamine transporter substrates. Curr Top Med Chem. 2006;6(17):1845-59.
REF 23Bioorg Med Chem Lett. 2010 Feb 1;20(3):1114-7. Epub 2009 Dec 6.Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.
REF 24Bioorg Med Chem. 2009 Mar 1;17(5):2047-68. Epub 2009 Jan 15.2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.
REF 25Bioorg Med Chem Lett. 2009 Oct 15;19(20):5893-7. Epub 2009 Aug 21.Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.
REF 26Bioorg Med Chem Lett. 2008 Sep 15;18(18):4940-3. Epub 2008 Aug 19.New iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter.
REF 27J Med Chem. 2004 Dec 2;47(25):6401-9.Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.
REF 28Bioorg Med Chem. 2008 Mar 15;16(6):2769-78. Epub 2008 Jan 11.Further structural optimization of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine and 1,4-diazabicyclo[3.3.1]nonane derivatives by introducing an exocyclic hydroxyl group: interaction with dopamine, serotonin, and norepinephrine transporters.
REF 29J Med Chem. 2008 Nov 27;51(22):7265-72.Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.
REF 30J Med Chem. 2006 Feb 23;49(4):1420-32.1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.
REF 31Bioorg Med Chem Lett. 2006 Aug 15;16(16):4345-8. Epub 2006 Jun 5.N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.
REF 32J Med Chem. 2010 Mar 11;53(5):2204-14.Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.
REF 33Bioorg Med Chem Lett. 2009 Apr 15;19(8):2329-32. Epub 2009 Feb 20.Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.
REF 34J Med Chem. 2009 Nov 12;52(21):6768-81.Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.
REF 35Bioorg Med Chem Lett. 2000 Nov 6;10(21):2445-7.3alpha-(4-Substituted phenyl)nortropane-2beta-carboxylic acid methyl esters show selective binding at the norepinephrine transporter.
REF 36Bioorg Med Chem. 2009 Oct 1;17(19):6890-7. Epub 2009 Aug 20.Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents fordepression.
REF 37J Med Chem. 2004 May 6;47(10):2624-34.Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters.
REF 38Bioorg Med Chem. 2009 Jan 1;17(1):337-43. Epub 2008 Nov 5.Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.
REF 39Bioorg Med Chem Lett. 2010 Jun 15;20(12):3788-92. Epub 2010 Apr 18.Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.
REF 40Bioorg Med Chem Lett. 2009 Dec 15;19(24):6865-8. Epub 2009 Oct 23.Synthesis and monoamine transporter affinity of 3alpha-arylmethoxy-3beta-arylnortropanes.
REF 41J Med Chem. 2007 May 31;50(11):2718-31. Epub 2007 May 10.Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate.
REF 42Bioorg Med Chem. 2010 Jan 15;18(2):640-9. Epub 2009 Dec 6.Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters.
REF 43Bioorg Med Chem Lett. 2009 Sep 1;19(17):4996-8. Epub 2009 Jul 16.Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter.
REF 44J Med Chem. 2006 Oct 19;49(21):6391-9.Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation.
REF 45J Med Chem. 1996 Oct 11;39(21):4139-41.3 alpha-(4'-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters: novel ligands with high affinity and selectivity at the dopamine transporter.
REF 46Bioorg Med Chem. 2010 Jun 1;18(11):4009-31. Epub 2010 Apr 13.Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted alpha-alkylthioamphetamines.
REF 47Bioorg Med Chem Lett. 2008 Aug 1;18(15):4355-9. Epub 2008 Jun 25.Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.
REF 48J Med Chem. 2010 Jun 24;53(12):4731-48.Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.
REF 49J Med Chem. 2007 Jul 26;50(15):3686-95. Epub 2007 Jun 30.Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.
REF 50Bioorg Med Chem Lett. 2009 Jan 1;19(1):58-61. Epub 2008 Nov 13.1-Naphthyl and 4-indolyl arylalkylamines as selective monoamine reuptake inhibitors.
REF 51Bioorg Med Chem Lett. 2009 Aug 15;19(16):4579-83. Epub 2009 Jul 2.Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.
REF 52J Med Chem. 2008 Jul 24;51(14):4150-69. Epub 2008 Jun 28.Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
REF 53Vanoxerine, a new drug for terminating atrial fibrillation and flutter. J Cardiovasc Electrophysiol. 2010 Mar;21(3):311-9. doi: 10.1111/j.1540-8167.2009.01622.x. Epub 2009 Oct 8.
REF 54Bioorg Med Chem. 2007 Jun 1;15(11):3649-60. Epub 2007 Mar 21.Tricyclic isoxazolines: identification of R226161 as a potential new antidepressant that combines potent serotonin reuptake inhibition and alpha2-adrenoceptor antagonism.
REF 55J Med Chem. 1997 Jun 6;40(12):1835-44.A technetium-99m SPECT imaging agent which targets the dopamine transporter in primate brain.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.